Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Return on Sales (2016 - 2025)

Historic Return on Sales for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to 0.06%.

  • Harvard Bioscience's Return on Sales rose 1600.0% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.62%, marking a year-over-year decrease of 4700.0%. This contributed to the annual value of 0.13% for FY2024, which is 1000.0% down from last year.
  • Per Harvard Bioscience's latest filing, its Return on Sales stood at 0.06% for Q3 2025, which was up 1600.0% from 0.11% recorded in Q2 2025.
  • In the past 5 years, Harvard Bioscience's Return on Sales ranged from a high of 0.08% in Q2 2022 and a low of 2.31% during Q1 2025
  • Its 5-year average for Return on Sales is 0.19%, with a median of 0.06% in 2025.
  • Its Return on Sales has fluctuated over the past 5 years, first soared by 2600bps in 2023, then plummeted by -21200bps in 2025.
  • Quarter analysis of 5 years shows Harvard Bioscience's Return on Sales stood at 0.02% in 2021, then tumbled by -526bps to 0.08% in 2022, then grew by 15bps to 0.06% in 2023, then surged by 103bps to 0.0% in 2024, then tumbled by -3043bps to 0.06% in 2025.
  • Its Return on Sales was 0.06% in Q3 2025, compared to 0.11% in Q2 2025 and 2.31% in Q1 2025.